Canopy Growth Co. (NASDAQ:CGC) Shares Sold by Baader Bank Aktiengesellschaft

Baader Bank Aktiengesellschaft lowered its holdings in Canopy Growth Co. (NASDAQ:CGC) by 32.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 77,461 shares of the company’s stock after selling 37,431 shares during the quarter. Baader Bank Aktiengesellschaft’s holdings in Canopy Growth were worth $210,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Geode Capital Management LLC acquired a new position in Canopy Growth in the third quarter valued at approximately $1,882,000. Sassicaia Capital Advisers LLC acquired a new position in shares of Canopy Growth in the 3rd quarter valued at $54,000. Centiva Capital LP purchased a new stake in Canopy Growth during the third quarter worth $257,000. Financial Advocates Investment Management acquired a new stake in Canopy Growth during the third quarter valued at $57,000. Finally, PFG Investments LLC purchased a new position in Canopy Growth in the third quarter valued at $54,000. 3.33% of the stock is currently owned by institutional investors and hedge funds.

Canopy Growth Trading Down 5.2 %

Shares of CGC stock opened at $1.99 on Friday. Canopy Growth Co. has a 1-year low of $1.96 and a 1-year high of $14.92. The company has a market cap of $259.56 million, a price-to-earnings ratio of -0.40 and a beta of 0.87. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.39 and a quick ratio of 1.07. The stock has a 50 day simple moving average of $2.87 and a 200-day simple moving average of $4.47.

Analyst Upgrades and Downgrades

Separately, Atb Cap Markets cut Canopy Growth from a “hold” rating to a “strong sell” rating in a research report on Monday, December 16th.

Canopy Growth Company Profile

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.